Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur.

Trial Profile

Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2014

At a glance

  • Drugs Buprenorphine (Primary) ; Oxycodone
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Dec 2014 The status is discontinued in Eudra but completed in CT.gov; retained as per Eudra info because it is a single centre study.
    • 11 Jun 2013 According to European Clinical Trials database, Status changed from recruiting to discontinued.
    • 11 Jun 2013 Last checked against European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top